S&P 500   3,333.08 (-1.19%)
DOW   28,947.77 (-0.93%)
QQQ   229.78 (-2.13%)
AAPL   312.52 (-2.43%)
FB   209.72 (-2.26%)
MSFT   178.10 (-3.43%)
GOOGL   1,486.99 (-1.98%)
AMZN   2,097.19 (-2.60%)
CGC   21.90 (-1.84%)
NVDA   293.22 (-5.01%)
BABA   212.60 (-2.49%)
MU   56.39 (-4.42%)
GE   12.28 (-2.00%)
TSLA   889.03 (-1.15%)
AMD   53.43 (-6.71%)
T   38.41 (-0.52%)
ACB   1.66 (-1.19%)
F   7.91 (-1.50%)
NFLX   380.00 (-1.55%)
BAC   34.20 (-1.89%)
DIS   138.93 (-1.03%)
S&P 500   3,333.08 (-1.19%)
DOW   28,947.77 (-0.93%)
QQQ   229.78 (-2.13%)
AAPL   312.52 (-2.43%)
FB   209.72 (-2.26%)
MSFT   178.10 (-3.43%)
GOOGL   1,486.99 (-1.98%)
AMZN   2,097.19 (-2.60%)
CGC   21.90 (-1.84%)
NVDA   293.22 (-5.01%)
BABA   212.60 (-2.49%)
MU   56.39 (-4.42%)
GE   12.28 (-2.00%)
TSLA   889.03 (-1.15%)
AMD   53.43 (-6.71%)
T   38.41 (-0.52%)
ACB   1.66 (-1.19%)
F   7.91 (-1.50%)
NFLX   380.00 (-1.55%)
BAC   34.20 (-1.89%)
DIS   138.93 (-1.03%)
S&P 500   3,333.08 (-1.19%)
DOW   28,947.77 (-0.93%)
QQQ   229.78 (-2.13%)
AAPL   312.52 (-2.43%)
FB   209.72 (-2.26%)
MSFT   178.10 (-3.43%)
GOOGL   1,486.99 (-1.98%)
AMZN   2,097.19 (-2.60%)
CGC   21.90 (-1.84%)
NVDA   293.22 (-5.01%)
BABA   212.60 (-2.49%)
MU   56.39 (-4.42%)
GE   12.28 (-2.00%)
TSLA   889.03 (-1.15%)
AMD   53.43 (-6.71%)
T   38.41 (-0.52%)
ACB   1.66 (-1.19%)
F   7.91 (-1.50%)
NFLX   380.00 (-1.55%)
BAC   34.20 (-1.89%)
DIS   138.93 (-1.03%)
S&P 500   3,333.08 (-1.19%)
DOW   28,947.77 (-0.93%)
QQQ   229.78 (-2.13%)
AAPL   312.52 (-2.43%)
FB   209.72 (-2.26%)
MSFT   178.10 (-3.43%)
GOOGL   1,486.99 (-1.98%)
AMZN   2,097.19 (-2.60%)
CGC   21.90 (-1.84%)
NVDA   293.22 (-5.01%)
BABA   212.60 (-2.49%)
MU   56.39 (-4.42%)
GE   12.28 (-2.00%)
TSLA   889.03 (-1.15%)
AMD   53.43 (-6.71%)
T   38.41 (-0.52%)
ACB   1.66 (-1.19%)
F   7.91 (-1.50%)
NFLX   380.00 (-1.55%)
BAC   34.20 (-1.89%)
DIS   138.93 (-1.03%)
Log in

ASX:AVH - Avita Medical Stock Price, Forecast & News

A$0.76
-0.02 (-2.55 %)
(As of 02/21/2020 02:10 PM ET)
Today's Range
A$0.76
Now: A$0.77
A$0.79
50-Day Range
A$0.00
MA: A$0.70
A$0.85
52-Week Range
A$0.13
Now: A$0.77
A$0.83
Volume9.68 million shs
Average VolumeN/A
Market Capitalization$1.47 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products for the treatment of burns, chronic wounds, and aesthetics indications. The company's patented and proprietary collection and application technology provides treatment solutions derived from a patient's own skin. Its lead product, RECELL System, is used in the treatment of various skin defects, such as burns and plastic reconstructive procedures. The company also offers ReGenerCell for chronic wounds and ReNovaCell for the restoration of pigmentation. Avita Medical Limited is based in Valencia, California.

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone661-367-9170

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$534,034.00
Cash FlowA$0.02 per share
Book ValueA$0.00 per share

Profitability

Miscellaneous

Employees55
Outstanding Shares1,922,880,000
Market Cap$1.47 billion
Next Earnings DateN/A
OptionableOptionable

Receive AVH News and Ratings via Email

Sign-up to receive the latest news and ratings for AVH and its competitors with MarketBeat's FREE daily newsletter.


Avita Medical (ASX:AVH) Frequently Asked Questions

What is Avita Medical's stock symbol?

Avita Medical trades on the ASX under the ticker symbol "AVH."

How were Avita Medical's earnings last quarter?

Avita Medical Ltd (ASX:AVH) released its quarterly earnings results on Thursday, February, 28th. The company reported ($0.02) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.01) by $0.01. View Avita Medical's Earnings History.

Has Avita Medical been receiving favorable news coverage?

Media stories about AVH stock have been trending extremely negative on Friday, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Avita Medical earned a news impact score of -4.2 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Avita Medical.

Who are some of Avita Medical's key competitors?

What other stocks do shareholders of Avita Medical own?

Who are Avita Medical's key executives?

Avita Medical's management team includes the folowing people:
  • Dr. Michael S. Perry, CEO & Director (Age 60)
  • Mr. Dale A. Sander, Chief Financial Officer (Age 59)
  • Mr. Timothy Rooney, Chief Admin. Officer
  • Mr. Andrew Quick, Sr. VP of Clinical Devel.
  • Ms. Erin Liberto, Chief Commercial Officer

What is Avita Medical's stock price today?

One share of AVH stock can currently be purchased for approximately A$0.77.

How big of a company is Avita Medical?

Avita Medical has a market capitalization of $1.47 billion and generates $534,034.00 in revenue each year. Avita Medical employs 55 workers across the globe.View Additional Information About Avita Medical.

What is Avita Medical's official website?

The official website for Avita Medical is http://www.avitamedical.com/.

How can I contact Avita Medical?

The company can be reached via phone at 661-367-9170.


MarketBeat Community Rating for Avita Medical (ASX AVH)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  13 (Vote Outperform)
Underperform Votes:  13 (Vote Underperform)
Total Votes:  26
MarketBeat's community ratings are surveys of what our community members think about Avita Medical and other stocks. Vote "Outperform" if you believe AVH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2020 by MarketBeat.com Staff

Featured Article: Swap

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel